Medpace Holdings Inc vs Prospect Capital Corporation — how do they compare? Medpace Holdings Inc trades at $530.22 (market cap $15.08B), while Prospect Capital Corporation trades at $2.15 (market cap $1.12B). The key difference: Medpace Holdings Inc is far larger — about 13.5× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays a 22.42% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | PSEC | |
|---|---|---|
Market Cap | $15.08B | $1.12B |
Sector | Technology | Financials |
52-Week High | $620.59 | $3.47 |
52-Week Low | $308.88 | $2.15 |
Enterprise Value | $14.55B | — |
Dividend Yield | — | 22.42% |
Trailing returns across standard periods
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →